Showing results (271-280 of 298) with videos related to

Sort By:
Pageof 30
European Heart Journal|September 1, 2024
Aortic valve replacement vs. conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trialMarko Banovic, Svetozar Putnik, Bruno R Da Costa, et al.
BMJ (Clinical Research Ed.)|March 24, 2022
Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE)Michael Fralick, Michael Colacci, Laveena Munshi, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 5, 2017
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysisStuart J Head, Bruno R da Costa, Berend Beumer, et al.
JACC. Cardiovascular Interventions|January 6, 2018
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access TrialGiuseppe Gargiulo, Sara Ariotti, Pascal Vranckx, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|November 5, 1997
The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux DiseaseI T Beck, M C Champion, S Lemire, et al.
Journal of Internal Medicine|October 17, 2017
Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohortsD Segna, D C Bauer, M Feller, et al.
JAMA Cardiology|March 20, 2024
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-AnalysisMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Circulation|October 25, 2017
Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial FibrillationChristine Baumgartner, Bruno R da Costa, Tinh-Hai Collet, et al.
Nature Medicine|January 15, 2026
Fractional flow reserve-guided percutaneous coronary intervention versus medical therapy for stable coronary artery disease: long-term results of the FAME 2 trialCarlos Collet, Thabo Mahendiran, William F Fearon, et al.
Lancet (London, England)|September 3, 2024
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trialsMarco Valgimigli, Sung-Jin Hong, Felice Gragnano, et al.
Pageof 30